Literature DB >> 26211886

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.

Donald Banerji1, Francesco Patalano2.   

Abstract

Entities:  

Keywords:  Dual bronchodilators; Exacerbations; LABA/ICS; LABA/LAMA; Lung function

Mesh：

Substances：

Year:  2015        PMID： 26211886     DOI： 10.1016/j.rmed.2015.07.009

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  2 in total

Review 1.  When is dual bronchodilation indicated in COPD?

Authors:  Mike Thomas; David Mg Halpin; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-03

2.  The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study.

Authors:  Tarek M Mostafa; Gamal A El-Azab; Ghada A Atia; Noran S Lotfy
Journal:  Curr Ther Res Clin Exp       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.